Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Structured Acupuncture Protocol on Symptom Burden, Quality of Life, and Neuropeptide Biomarkers in Patients With End-Stage Kidney Disease Undergoing Hemodialysis or Peritoneal Dialysis: A Prospective, Randomized, Blinded, Sham-Controlled Trial

NCT07887607 is registered in ClinicalTrials.gov with University General Hospital of Heraklion as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07887607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Structured Acupuncture Protocol on Symptom Burden, Quality of Life, and Neuropeptide Biomarkers in Patients With End-Stage Kidney Disease Undergoing Hemodialysis or Peritoneal Dialysis: A Prospective, Randomized, Blinded, Sham-Controlled Trial
Lead sponsor
University General Hospital of Heraklion
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
September 30, 2029
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage kidney disease (eskd)

Arms

As registered; 2 arms.

  • Acupuncture ExperimentalAcupuncture

    Participants will receive a structured acupuncture protocol in addition to usual care. Treatment will consist of 2-3 sessions per week for up to 24 sessions over 8-12 weeks. The protocol will include a standardized core set of acupuncture points, with limited individualized additional points based on clinical presentation and Traditional Chinese Medicine assessment. Body acupuncture and auricular acupuncture may be used. Acupuncture will be performed by trained members of the research team at the University General Hospital of Heraklion.

  • Sham Acupuncture Sham comparatorSham Acupuncture

    Participants will receive sham acupuncture in addition to usual care, with the same treatment frequency, session duration, and general procedural setting as the experimental group. Sham acupuncture will be performed at non-acupuncture points using superficial needle insertion (1-2 mm), without elicitation of deqi, needle manipulation, or electrical stimulation. No modification of usual care will be made as part of the sham intervention.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in health-related quality of life assessed by KDQOL-36 domain scores Baseline, week 6, week 12, and week 24

    Health-related quality of life will be assessed using the Kidney Disease Quality of Life 36-item questionnaire (KDQOL-36). The instrument includes the SF-12 Physical Component Summary (PCS) and Mental Component Summary (MCS), as well as three kidney disease-specific domains: Symptoms and Problems, Effects of Kidney Disease, and Burden of Kidney Disease. Scores are transformed to a 0-100 scale, with higher scores indicating better health-related quality of life. The KDQOL-36 will be administered at baseline, at week 6, at the end of the 12-week intervention, and at the 12-week post-intervention follow-up (24 weeks). Changes over time will be compared between the acupuncture and sham acupuncture groups.

Papers

PubMed papers this trial cites; 5 papers, results papers first, then newest first.

Source: PubMed, NCBI/NLM (public domain).

Lead sponsor's other trials

University General Hospital of Heraklion, most recent start first.

Similar trials

Same condition (Kidney Failure, Chronic) and phase, most recent start first.